Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Resumen

Using a uniquely promiscuous engineered glycosyltransferase (GT) derived from the macrolide-inactivating GT OleD, a single-step asymmetric glucosylation of one 'arm' of the drug mitoxantrone was efficiently achieved in high stereo- and regiospecificity. The synthesis, structural elucidation, and anticancer activity of the corresponding mitoxantrone 4′-β-d-glucoside are described.

Idioma originalEnglish
Páginas (desde-hasta)2786-2788
Número de páginas3
PublicaciónOrganic Letters
Volumen13
N.º10
DOI
EstadoPublished - may 20 2011

Financiación

FinanciadoresNúmero del financiador
National Institute of Allergy and Infectious F32-AI286447 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI168214 Jason W. Rosch Diseases National Institute of Allergy and Infectious P30 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R00-AI166116 Christopher D. Radka Diseases National Institute of Allergy and Infectious T32-AI106700 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI192221 Jason W. Rosch Diseases National Inst...R01AI052218

    ASJC Scopus subject areas

    • Biochemistry
    • Physical and Theoretical Chemistry
    • Organic Chemistry

    Huella

    Profundice en los temas de investigación de 'Asymmetric enzymatic glycosylation of mitoxantrone'. En conjunto forman una huella única.

    Citar esto